The disclosure provides, among other things, molecular markers for categorizing the neoplastic state of a patient, methods for using the molecular markers in diagnostic tests, nucleic acid and amino acid sequences related to the molecular markers, reagents for detection of molecular markers, and methods for identifying candidate molecular markers in highly parallel gene expression data.

 
Web www.patentalert.com

< Pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides

< CIDE-B polypeptides

> Anti-mesothelin antibodies having high binding affinity

> Crystal forms of azithromycin

~ 00275